Wellington Management Company »

Alpine Immune Sciences shares owned by Wellington Management Company

Quarter-by-quarter ownership of Alpine Immune Sciences (ALPN) shares owned by Wellington Management Company from 13F filings

Historical chart of Wellington Management Company investment in Alpine Immune Sciences

Tip: Access up to 7 years of quarterly data

All positions including Alpine Immune Sciences held by Wellington Management Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alpine Immune Sciences by Wellington Management Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.1M 110k 19.06
2023-09-30 $455k 40k 11.45

More positions owned by Wellington Management Company

Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Amazon (AMZN)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Merck & Co (MRK)
Pfizer (PFE)
Eli Lilly & Co. (LLY)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Danaher Corporation (DHR)
NVIDIA Corporation (NVDA)
Procter & Gamble Company (PG)
TJX Companies (TJX)
Mastercard Incorporated Cl A (MA)

View all positions for Wellington Management Company

Top funds holding Alpine Immune Sciences

Decheng Capital
RA Capital Management
Lynx1 Capital Management
Dr. Jeffrey R. Jay, M.D.
BlackRock
Paradigm Biocapital Advisors
Frazier Life Sciences Management
Vanguard Group
Cormorant Asset Management
OrbiMed Advisors
T. Rowe Price Associates
Commodore Capital
Octagon Capital Advisors
Franklin Resources
Citadel Advisors

View all funds holding Alpine Immune Sciences